BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/6/2021 2:31:17 AM | Browse: 683 | Download: 922
 |
Received |
|
2021-02-04 04:58 |
|
Peer-Review Started |
|
2021-02-04 05:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-19 01:04 |
|
Revised |
|
2021-04-26 15:14 |
|
Second Decision |
|
2021-05-27 09:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-27 09:44 |
|
Articles in Press |
|
2021-05-27 09:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-30 02:00 |
|
Publish the Manuscript Online |
|
2021-07-06 02:31 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Georgios Axiaris, Evanthia Zampeli, Spyridon Michopoulos and Giorgos Bamias |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giorgos Bamias, MD, PhD, Associate Professor, GI Unit, 3rd Academic Dpt. of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, 44 Kifisias Avenue, Athens 11526, Greece. gbamias@gmail.com |
| Key Words |
Hepatitis B virus; Inflammatory bowel disease; Reactivation; Immunosuppression; Vaccination; Prophylaxis |
| Core Tip |
The management of hepatitis B virus (HBV) infection poses significant challenges for patients with inflammatory bowel disease (IBD). Lower rates of vaccination for HBV have been reported in this population and immunization programs should be encouraged and intensively implemented. In addition, patients who receive immune-modifying therapies may develop suboptimal responses to vaccination. In the presence of present or past HBV infection, immunosuppressive therapies may increase the risk for reactivation of the virus with adverse clinical outcomes. Close surveillance and/or prophylactic anti-viral treatment may be employed depending on the status of HBV infection and the IBD-specific therapy. |
| Publish Date |
2021-07-06 02:31 |
| Citation |
Axiaris G, Zampeli E, Michopoulos S, Bamias G. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment. World J Gastroenterol 2021; 27(25): 3762-3779 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i25/3762.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i25.3762 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
